Matisse Pharmaceuticals (private company)
See something wrong or missing? Let us know
Offices:Amsterdam
Industry:BiotechHealth servicesPharma
Business model:B2B
Matisse Pharmaceuticals is a Dutch biotechnology startup dedicated to development of pharmaceutical therapies used to treat disorders that are associated with fulminant inflammation such as sepsis.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.98M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Matisse Pharmaceuticals
Name | Criteria | |
---|---|---|
![]() |
Octarine Bio
67%
|
|
![]() |
PEP-Therapy
67%
|
|
![]() |
Oncorena
67%
|
|
![]() |
InnoSIGN
67%
|
|
![]() |
Resistell
67%
|
|
![]() |
Mybacs
67%
|
|
![]() |
Metrion Biosciences
67%
|
|
![]() |
Gradientech
63%
|
|
![]() |
Lys Therapeutics
63%
|
|
![]() |
Navignostics
63%
|
|